KALA BIO, Inc. (KALA) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -84.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -84.0% |
| EPS Growth (YoY) | -90.1% |
| Price / Book | 1.42 |
| Price / Sales | 12.56 |
| Altman Z-Score | 68.12 (safe) |
| Sector P/E (Healthcare) | 21.7 |
KALA overview · KALA earnings · KALA KPIs · KALA investor relations · KALA ownership · KALA peers · KALA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.